Biofourmis logo

Biofourmis

Biofourmis is a global health IT start-up in Massachusetts that focuses on personalized care and therapies using digital therapeutics.

7

Funding Rounds

$443.5m

Money raised

Overview

Biofourmis is a global health IT start-up in Massachusetts that focuses on personalized care and therapies using digital therapeutics.

Funding

Funding series

Funding Series Analysis

The company Biofourmis has raised a total of $438.5m in funding over 7 rounds.

Key Insights:

  • Biofourmis Series D round, April 2022: $300m
  • Biofourmis Series C round, September 2020: $100m
  • Biofourmis Series B round, May 2019: $35m
  • Biofourmis Series A round, May 2018: $2m
  • Biofourmis Seed round, May 2017: $500k
  • Biofourmis Angel round, August 2016: $1m
  • Biofourmis funding round, December 2017: $5m
Biofourmis logo
Biofourmis Series D round, April 2022 $300m
Biofourmis logo
Biofourmis Series C round, September 2020 $100m
Biofourmis logo
Biofourmis Series B round, May 2019 $35m
Biofourmis logo
Biofourmis Series A round, May 2018 $2m
Biofourmis logo
Biofourmis Seed round, May 2017 $500k
Biofourmis logo
Biofourmis Angel round, August 2016 $1m
Biofourmis logo
Biofourmis funding round, December 2017 $5m

Industries

Biofourmis is active in the following industries:
  • Drug discovery
  • Artificial Intelligence (AI)
  • Clinical trial
  • Drug development
  • Predictive analytics
  • Remote patient monitoring
  • Patient monitoring
  • Biosensor
  • Digital therapeutics
  • Biomedical engineering
  • Electronic health record
  • Healthcare
  • Technology
  • Biology
  • Biotechnology
  • Digital health
  • Therapeutics
  • Personal Health
  • Analytics
  • MHealth
  • Engineering